Regado Biosciences to Provide Third Quarter 2014 Financial Results

BASKING RIDGE, N.J., Oct. 30, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), today announced that it will hold a conference call and live audio webcast on Thursday, November 6, 2014, at 8:30 a.m. EST to discuss its third quarter 2014 financial results.

Interested participants and investors may access the conference call by dialing (888) 347-1165 for domestic callers or (412) 902-4276 for international callers. The conference call will be webcast live under the investor relations section of the Regado website at www.regadobio.com and will be archived there for 60 days following the call.

ABOUT REGADO BIOSCIENCES

Regado Biosciences, Inc., is a development stage biotechnology company whose mission is to transform lives through the discovery and development of novel therapeutics. Regado applies its expertise to the development of therapies using actively controlled aptamer technology, which is designed to give physicians the ability to control the therapeutic effect in real time. More information can be found at www.regadobio.com.

Investor Relations Contact:
Don Elsey, CFO
Regado Biosciences, Inc.
908-580-2113
[email protected]                    

Media Contacts:
David Schull or Lena Evans
Russo Partners
212-845-4271                                                 
212-845-4262
[email protected]
[email protected]

SOURCE Regado Biosciences, Inc.

Related Links

http://www.regadobio.com